Arkolith/Insider Trading/ATAI/Form 4

Apeiron Investment Group Ltd.

10% OwnerATAI Life Sciences N.V. (ATAI) · full profile →Form 4 · filed Feb 19, 2025
Net Buying
Open-Market Buys
$22.8M
Open-Market Sells
$0
Net Open-Market Flow
$22.8M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2025Buy(P)10.8M$2.10$22.8M40.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-023436) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML